Tower Research Capital (TRC)’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-141
| Closed | – | – | 4632 |
|
|
2018
Q4 | $0 | Buy |
+141
| New | – | ﹤0.01% | 4658 |
|
|
2018
Q1 | – | Sell |
-61
| Closed | – | – | 4229 |
|
|
2017
Q4 | $0 | Buy |
+61
| New | – | ﹤0.01% | 4422 |
|
|
2017
Q3 | – | Sell |
-10,365
| Closed | -$14K | – | 4449 |
|
|
2017
Q2 | $14K | Buy |
+10,365
| New | +$14K | ﹤0.01% | 1437 |
|
|
2017
Q1 | – | Sell |
-3,870
| Closed | -$20K | – | 4329 |
|
|
2016
Q4 | $20K | Buy |
+3,870
| New | +$20K | ﹤0.01% | 2167 |
|
|
2016
Q1 | – | Sell |
-528
| Closed | -$3K | – | 5327 |
|
|
2015
Q4 | $3K | Sell |
528
-1,387
| -72% | -$7.88K | ﹤0.01% | 3578 |
|
|
2015
Q3 | $15K | Buy |
1,915
+362
| +23% | +$2.84K | ﹤0.01% | 1997 |
|
|
2015
Q2 | $10K | Buy |
1,553
+1,457
| +1,518% | +$9.38K | ﹤0.01% | 2737 |
|
|
2015
Q1 | $1K | Sell |
96
-160
| -63% | -$1.67K | ﹤0.01% | 4217 |
|
|
2014
Q4 | $1K | Buy |
+256
| New | +$1K | ﹤0.01% | 3803 |
|
|
2013
Q3 | – | Sell |
-100
| Closed | – | – | 4987 |
|
|
2013
Q2 | $0 | Buy |
+100
| New | – | ﹤0.01% | 4008 |
|